Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  EKF Diagnostics Holdings plc    EKF   GB0031509804

EKF DIAGNOSTICS HOLDINGS PLC

(EKF)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
63(c) 64(c) 62(c) 62.75(c) 60.5(c) Last
575 501 378 705 596 399 687 717 682 663 Volume
0.00% +1.59% -3.13% +1.21% -3.59% Change
More quotes
Financials
Sales 2020 62,7 M 83,6 M 83,6 M
Net income 2020 14,2 M 18,9 M 18,9 M
Net cash position 2020 21,7 M 29,0 M 29,0 M
P/E ratio 2020 20,4x
Yield 2020 1,63%
Sales 2021 49,9 M 66,6 M 66,6 M
Net income 2021 6,96 M 9,29 M 9,29 M
Net cash position 2021 26,8 M 35,7 M 35,7 M
P/E ratio 2021 41,6x
Yield 2021 1,67%
Capitalization 286 M 381 M 381 M
EV / Sales 2020 4,21x
EV / Sales 2021 5,18x
Nbr of Employees 309
Free-Float 89,4%
More Financials
Company
EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of... 
More about the company
Notations Surperformance© of EKF Diagnostics Holdings plc
Trading Rating : - Investor Rating :
More Ratings
All news about EKF DIAGNOSTICS HOLDINGS PLC
11/24EKF DIAGNOSTICS : Update on strategic investment in Trellus Health & Notice of G..
PU
11/09EKF DIAGNOSTICS : Trading update
PU
11/05EKF DIAGNOSTICS HOLDINGS PLC : Ex-dividend day for final dividend
FA
10/29EKF DIAGNOSTICS : launches PrimeStore® MTM pathogenic sample collection and tran..
PU
10/28EKF DIAGNOSTICS : and Kantaro Biosciences partner to market quantitative COVID a..
PU
10/26EKF DIAGNOSTICS : Dividend confirmation
PU
10/02EKF DIAGNOSTICS : Trading update
PU
09/15EKF DIAGNOSTICS : Dividend Timetable Amendment
PU
09/14EKF DIAGNOSTICS : Half-year Report
PU
09/10EKF DIAGNOSTICS : Notice of results
PU
08/05EKF DIAGNOSTICS : New UK supply contract for COVID-19 sample collection kits
PU
07/14EKF DIAGNOSTICS : Trading update and Update on COVID-19 related manufacturing co..
PU
07/10EKF DIAGNOSTICS : introduces novel molecular transport media for dual COVID-19 a..
PU
05/21EKF DIAGNOSTICS : secures COVID-19 novel sample collection kit manufacturing and..
PU
05/15EKF DIAGNOSTICS : Update on trading and COVID-19 related manufacturing contract
PU
More news
News in other languages on EKF DIAGNOSTICS HOLDINGS PLC
09/09EKF DIAGNOSTICS HOLDINGS PLC : Veröffentlichung des Halbjahresergebnisses
09/09EKF DIAGNOSTICS HOLDINGS PLC : publication des résultats semestriels
2016EKF DIAGNOSTICS HOLDING PLC : Veröffentlichung des Halbjahresergebnisses
2016EKF DIAGNOSTICS HOLDING PLC : publication des résultats semestriels
More news
Chart EKF DIAGNOSTICS HOLDINGS PLC
Duration : Period :
EKF Diagnostics Holdings plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EKF DIAGNOSTICS HOLDINGS PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 65,00 GBX
Last Close Price 62,75 GBX
Spread / Highest target 3,59%
Spread / Average Target 3,59%
Spread / Lowest Target 3,59%
EPS Revisions
Managers
NameTitle
Julian Huw Baines Chief Executive Officer & Executive Director
Christopher Harwood Bernard Mills Non-Executive Chairman
Richard Anthony Evans COO, Finance Director & Executive Director
Adam Reynolds Independent Non-Executive Director
Carl Dominic Contadini Non-Executive Director
Sector and Competitors